Balancing Cost and Access: The Pharmacoeconomic Challenge of Insulin Therapy in Diabetes Management
Year: 2022
Type: editorial
Abstract: Diabetes mellitus, a chronic metabolic disorder, continues to impose an increasing global health and economic burden. Central to its management, particularly in type 1 diabetes and advanced type 2 diabetes, is insulin therapy—a lifesaving intervention discovered over a century ago. Despite its clinical efficacy, the cost of insulin remains a critical challenge, raising concerns about access and adherence, particularly in low- and middle-income countries (LMICs). This editorial explores the pharmacoeconomic barriers surrounding insulin therapy and emphasizes the urgent need for strategies to ensure equitable access.
Source: Innovations in Pharmacy Planet
Author: Priya Mantri
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: hybrid
OpenAlex ID: W7218041507
